Education and treatment adherence during the COVID-19 pandemic. Response to: 'Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic' by Khabbazi et al
- PMID: 32895238
- DOI: 10.1136/annrheumdis-2020-218791
Education and treatment adherence during the COVID-19 pandemic. Response to: 'Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic' by Khabbazi et al
Keywords: antirheumatic agents; autoimmune diseases; therapeutics.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Treatment adherence behaviours in rheumatic diseases during COVID-19 pandemic: a Latin American experience.Ann Rheum Dis. 2021 Jun;80(6):e85. doi: 10.1136/annrheumdis-2020-218198. Epub 2020 Jun 23. Ann Rheum Dis. 2021. PMID: 32576568 No abstract available.
-
Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic.Ann Rheum Dis. 2022 Oct;81(10):e200. doi: 10.1136/annrheumdis-2020-218756. Epub 2020 Sep 7. Ann Rheum Dis. 2022. PMID: 32895235 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
